Keyphrases
Proteasome Inhibition
100%
Visceral Leishmaniasis
100%
Preclinical Candidate
100%
Compound 8
100%
Leishmania Donovani
75%
Leishmania Infantum
50%
New Drugs
25%
Mutagenesis
25%
Trypanosoma Cruzi (T. cruzi)
25%
Mode of Action
25%
Protozoan Parasites
25%
Human Parasite
25%
Clinically Significant
25%
Chymotrypsin
25%
Pharmacokinetic Properties
25%
Safety Profile
25%
Neglected Tropical Diseases
25%
Mouse Infection
25%
Leishmania Tarentolae
25%
Miltefosine
25%
Parasitic Diseases
25%
Current Therapies
25%
Drug Candidates
25%
Repurposing
25%
Developability
25%
In Vivo Efficacy
25%
Human Trials
25%
Antileishmanial
25%
Kinetoplastid Parasites
25%
Resource-poor Settings
25%
20S Proteasome
25%
Proteasome Subunits
25%
High-resolution cryo-EM
25%
Cryo-EM Structure
25%
Pharmacology, Toxicology and Pharmaceutical Science
Proteasome
100%
Visceral Leishmaniasis
100%
Leishmania infantum
50%
Kinetoplastida
25%
Clinical Trial
25%
Trypanosoma Cruzi
25%
Protozoon
25%
Infection
25%
Cryo-Electron Microscopy
25%
Mutagenesis
25%
Mouse Model
25%
Chymotrypsin
25%
Parasitosis
25%
Leishmania tarentolae
25%
Miltefosine
25%
Repurposing
25%
Hexachlorophene
25%
Pharmacokinetics
25%
Tropical Disease
25%
Immunology and Microbiology
Proteasome
100%
Visceral Leishmaniasis
100%
Parasitology
50%
Leishmania infantum
50%
Protozoa
25%
Trypanosoma Cruzi
25%
Mutagenesis
25%
Pharmacokinetics
25%
Mouse Model
25%
Kinetoplastida
25%
Infectious Disease
25%
Cryo-Electron Microscopy
25%
Leishmania tarentolae
25%